Therapeutics
High-fidelity iPSC-derived cell types for regenerative medicine and cell therapy — engineered for reproducibility, scalability, and clinical translation.
Pioneering iPSC-Derived Cell Therapy & Regenerative Medicine
At Ricoh Biosciences, we leverage our proprietary iPSC differentiation technology to develop high-quality, functional cells for regenerative medicine and cell therapy applications. Our expertise in transcription factor-based differentiation allows us to rapidly generate clinically relevant cell types with high reproducibility, providing a scalable foundation for next-generation therapies.
Our Pipeline
An overview of our internal iPSC-derived cell therapy programs and their current stage of clinical development.
| Indication | Cell Type | Discovery | Preclinical | IND | Phase 1 | Phase 2 | Phase 3 | Approval |
|---|---|---|---|---|---|---|---|---|
| Parkinson’s Disease (PD) | Dopaminergic Neurons |
|
||||||
| Alzheimer’s Disease (AD) | Excitatory Neurons |
|
||||||
| Alzheimer’s Disease (AD) | Microglia |
|
||||||
| Amyotrophic Lateral Sclerosis (ALS) | Motor Neurons |
|
||||||
| Multiple Sclerosis (MS) | Oligodendrocytes |
|
||||||
| Cancer | T-Cells |
|
||||||
Our Approach
We focus on advancing iPSC-derived cell therapies by:
- Developing high-quality, functional cell types for therapeutic use
- Optimizing differentiation protocols for clinical translation
- Establishing scalable manufacturing to meet regulatory and commercial requirements
Partnership Opportunities
We collaborate with partners to advance iPSC-derived therapies. Our flexible engagement model provides them with:
- Access to our proprietary iPSC differentiation technology
- Opportunities to co-develop cell therapies for clinical applications
- Scalable cell manufacturing capabilities to support clinical translation
Request a Free Consultation
Work directly with our scientific team to evaluate feasibility, timelines, scale, and validation strategies for your program.
Online Marketplaces
Our products and services are available through ScienceExchange and Scientist.com for efficient, compliant procurement with existing vendor frameworks.
"*" indicates required fields